Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Type of study
Publication year range
1.
Clín. investig. arterioscler. (Ed. impr.) ; 32(3): 126-128, mayo-jun. 2020.
Article in Spanish | IBECS | ID: ibc-193358

ABSTRACT

Presentamos el caso de un síndrome coronario agudo en un paciente de 30 años con trombocitemia esencial. Los síndromes coronarios agudos ocurren en el 9% de los casos en estos pacientes, y su manejo constituye todo un reto para el cardiólogo, en concreto, en cuanto a la elección del tratamiento antiagregante más adecuado y su duración, considerando que estos pacientes tienen por una parte un elevado riesgo trombótico y, además, un riesgo hemorrágico no despreciable


We present the case is presented of an acute coronary syndrome in a 30-year-old patient with essential thrombocythaemia. Acute coronary syndromes occur in 9% of cases in these patients, and their management constitutes a challenge for the cardiologist, specifically in terms of choosing the most appropriate antiplatelet therapy and its duration, taking into account that these patients have a high thrombotic risk, as well as a considerable haemorrhagic risk


Subject(s)
Humans , Male , Adult , Acute Coronary Syndrome/etiology , Thrombocythemia, Essential/complications , Platelet Aggregation Inhibitors/administration & dosage , Acute Coronary Syndrome/therapy , Chest Pain/etiology , Echocardiography , Cardiac Catheterization , Thrombocythemia, Essential/diagnosis
2.
Clin Investig Arterioscler ; 32(3): 126-128, 2020.
Article in English, Spanish | MEDLINE | ID: mdl-31980199

ABSTRACT

We present the case is presented of an acute coronary syndrome in a 30-year-old patient with essential thrombocythaemia. Acute coronary syndromes occur in 9% of cases in these patients, and their management constitutes a challenge for the cardiologist, specifically in terms of choosing the most appropriate antiplatelet therapy and its duration, taking into account that these patients have a high thrombotic risk, as well as a considerable haemorrhagic risk.


Subject(s)
Acute Coronary Syndrome/diagnosis , Platelet Aggregation Inhibitors/administration & dosage , Thrombocythemia, Essential/diagnosis , Acute Coronary Syndrome/drug therapy , Acute Coronary Syndrome/etiology , Adult , Humans , Male , Platelet Aggregation Inhibitors/adverse effects , Thrombocythemia, Essential/complications , Thrombocythemia, Essential/drug therapy , Thrombosis/etiology , Thrombosis/prevention & control
SELECTION OF CITATIONS
SEARCH DETAIL
...